What is the ticker symbol for Albireo Pharma?

Albireo Pharma trades under the ticker ALBO on NASDAQ.

What sector does Albireo Pharma operate in?

Albireo Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ALBO in a portfolio?

PortView shows ALBO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Albireo Pharma (ALBO) Stock Analysis

NASDAQHealthcareBiotechnology

$44.15+0.00%

1-year price historyRange $16.32 – $44.95

52-week range$44.15

$16.02$45.23

What Albireo Pharma does

Albireo Pharma, Inc. is a biopharmaceutical company with marketed products, dedicated to researching, developing, and commercializing new treatments that modify bile acids. The company primarily targets rare liver diseases in children, as well as various other conditions affecting the liver or digestive system. Its portfolio includes Bylvay, a treatment approved for progressive familial intrahepatic cholestasis. Bylvay is also in advanced (Phase III) clinical trials for further pediatric indications such as biliary atresia and Alagille syndrome, which are both uncommon and serious childhood disorders. Additionally, Albireo offers Elobixibat, prescribed for the management of persistent constipation and other functional gastrointestinal issues. Albireo is further advancing its pipeline with A3907, currently undergoing early-stage (Phase I) clinical investigation for adult liver diseases, and A2342, a preclinical candidate designed to address adult viral and liver conditions. The company holds a licensing agreement with EA Pharma Co., Ltd. concerning the development and market rollout of Elobixibat. Albireo Pharma, Inc.'s headquarters are located in Boston, Massachusetts.

Key metrics

Market cap

$915.89M

P/E (TTM)

-6.63

EPS (TTM)

$-6.66

Beta

1.04

Dividend yield

0.00%

Revenue / share

$2.11

50-day avg

$38.96

200-day avg

$25.30

52-week high

$45.23

52-week low

$16.02

CEO

Ronald H. W. Cooper

ETFs linked to ALBO

Broad-market and Healthcare sector ETFs an investor holding Albireo Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ALBO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALBO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Albireo Pharma?: Albireo Pharma trades under the ticker ALBO on NASDAQ.
Which exchange is ALBO listed on?: ALBO is listed on NASDAQ.
What sector does Albireo Pharma operate in?: Albireo Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ALBO in a portfolio?: PortView shows ALBO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.